daunorubicin has been researched along with Carcinoma, Renal Cell in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altman, J; Kuzel, T; Parajuli, R; Perdekamp, M; Tallman, M | 1 |
Bourgeade, MF; Carvalho, G; Chapel, A; Charpentier, B; Cherbonnier, C; Hirsch, F; Kroemer, G; Lefaucheur, C; Métivier, D; Pallardy, M | 1 |
Ballard, ET; Huang, FS; Stern, LE; Warner, BW; Zwerdling, T | 1 |
Aiken, PM; Gottesman, MM; Merlino, GT; Mickisch, GH; Pastan, I | 1 |
Ahmann, FR; Chapman, R; Crawford, ED; Goodman, P; Lowe, BA; Natale, RB; Spicer, CF; Stephens, RL | 1 |
Gröne, E; Gröne, HJ; Helmchen, U; Osborn, M; Weber, K | 1 |
Broxterman, HJ; de Lange, P; Keizer, HG; Kuiper, CM; Lankelma, J; Pinedo, HM; Quak, JJ; Scheper, RJ; Schuurhuis, GJ; van der Hoeven, JJ | 1 |
Ahmed, T; Budman, D; Scher, HI; Sordillo, P; Watson, RC; Yagoda, A | 1 |
8 other study(ies) available for daunorubicin and Carcinoma, Renal Cell
Article | Year |
---|---|
Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association?
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Colonic Neoplasms; Colonic Polyps; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Idarubicin; Indoles; Kidney Neoplasms; Leukemia, Promyelocytic, Acute; Lung Neoplasms; Male; Mercaptopurine; Methotrexate; Middle Aged; Neoplasms, Second Primary; Pyrroles; Remission Induction; Sunitinib; Time Factors; Tretinoin | 2010 |
Chemosensitization by erythropoietin through inhibition of the NF-kappaB rescue pathway.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Death; Cell Line, Tumor; Daunorubicin; Erythropoietin; Humans; Janus Kinase 2; Kidney Neoplasms; NF-kappa B; Protein Transport; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptors, Erythropoietin; Signal Transduction; U937 Cells; Vinblastine | 2005 |
Renal cell carcinoma as a secondary malignancy after treatment of acute promyelocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cerebral Infarction; Child; Chromosomes, Human, Pair 17; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Humans; Hypertension; Kidney Failure, Chronic; Leukemia, Promyelocytic, Acute; Male; Neoplasms, Second Primary; Obesity; Remission Induction; Thioguanine | 2001 |
New potent verapamil derivatives that reverse multidrug resistance in human renal carcinoma cells and in transgenic mice expressing the human MDR1 gene.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Renal Cell; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Genes; Humans; Kidney Neoplasms; Male; Membrane Glycoproteins; Mice; Mice, Transgenic; Neoplasm Proteins; Tumor Cells, Cultured; Verapamil; Vinblastine | 1991 |
Evaluation of menogaril in renal cell carcinoma. A Southwest Oncology Group phase II study (8504).
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Daunorubicin; Drug Evaluation; Humans; Kidney Neoplasms; Menogaril; Nogalamycin | 1990 |
Coexpression of keratin and vimentin in damaged and regenerating tubular epithelia of the kidney.
Topics: Animals; Carcinoma, Renal Cell; Daunorubicin; Epithelium; Humans; Hypertension, Renovascular; Immunohistochemistry; Keratins; Kidney Diseases; Kidney Neoplasms; Kidney Tubular Necrosis, Acute; Kidney Tubules; Male; Rats; Rats, Inbred Strains; Regeneration; Vimentin | 1987 |
Immunohistochemical detection of P-glycoprotein in human tumor cells with a low degree of drug resistance.
Topics: Adult; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Renal Cell; Daunorubicin; Drug Resistance; Female; Humans; Kidney Neoplasms; Membrane Glycoproteins; Tumor Cells, Cultured; Vincristine | 1989 |
Phase-II trial of 4-demethoxydaunorubicin (DMDR) for advanced hypernephroma.
Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Kidney Neoplasms; Male; Middle Aged | 1985 |